| Amanda Fabian, PA-C | |
|
2855 10th St Ste B, Gering, NE 69341-2202 | |
| (308) 633-1325 | |
| Not Available |
| Full Name | Amanda Fabian |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2855 10th St Ste B, Gering, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679026231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 2337 (Nebraska) | Primary |
| 363AM0700X | Physician Assistant - Medical | PA962 (Wyoming) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Fabian, PA-C 2855 10th St Ste B, Gering, NE 69341-2202 Ph: (308) 633-1325 | Amanda Fabian, PA-C 2855 10th St Ste B, Gering, NE 69341-2202 Ph: (308) 633-1325 |
News Archive
News outlets report on how the delivery of health care is being changed by empowered patients.
Neovasc Inc. today announced that it has completed the final tranche of a previously announced non-brokered private placement. The aggregate gross proceeds of the financing totaled $1.537 million through placement of approximately 5.692 million units at a price of $0.27 per unit, comprised of a first tranche of $1.329 million announced January 28, 2010 and this second tranche of $208,000.
Inhibitex, Inc. today announced that the independent data safety monitoring board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with complete 30-day follow-up safety data on the third quartile (75%) of the patients that the Company plans to enroll in the trial. Based upon its review, the DSMB recommended that the trial continue to completion without modification.
Sonomax Hearing Healthcare Inc. (SHH:TSX Venture Exchange) announces objective, scientific proof of the company's ability to develop a technology to produce an off-the-shelf, self-fitting, custom earpiece.
Allos Therapeutics, Inc. today announced that the Journal of Clinical Oncology has published data from the Company's pivotal Phase 2 PROPEL study demonstrating clinical activity of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 5 days ago
Carol M Herman, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 975 Crescent Dr, Gering, NE 69341 Phone: 308-632-2540 Fax: 308-633-2650 | |
Mr. Joshua Dean, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1275 Sage St, Gering, NE 69341 Phone: 308-436-2101 | |
John Carrington, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3350 10th St, Gering, NE 69341 Phone: 308-635-3089 Fax: 308-635-0264 |